Evotec Investor
Evotec is a drug discovery alliance company providing drug discovery solutions to pharmaceutical and biotechnology companies.
.jpg)
.png)
Funding Status:
IPO
Industry:
End-to-End Drug Development
Estimated Revenue:
$100M to $500M
Technology:
Biopharma, Biotechnology, Pharmaceutical
Acquisitions Number:
Made Acquisitions
Number Of Exists:
2
Headquarters:
Hamburg, Hamburg, Germany
Total Funding:
733436691.0
Last Funding Date:
2023-02-10
Last Funding Type:
Post-IPO Debt
Investor Type:
Not Classified
Employee Number:
1001-5000
Investors Number:
10.0
Founded Date:
1993-01-01